How to access Vumerity from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-24
An Emirati patient with relapsing multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting, and active secondary-progressive disease, may receive a prescription for Vumerity (diroximel fumarate) from their treating neurologist. Vumerity is FDA-approved and developed by Biogen. It is an oral fumarate structurally designed to deliver the same active metabolite (monomethyl fumarate) as dimethyl fumarate (Tecfidera), with a clinical-trial tolerability profile that generally shows lower rates of gastrointestinal adverse events. In the Kingdom of the UAE, Vumerity is not routinely registered for outpatient dispensing, and access is typically coordinated through the named-patient import pathway via UAE Ministry of Health and Prevention (MoHAP).
This guide explains the pathway, documentation your physician prepares, typical timing and how quotes work, and where Reserve Meds fits in.
Ask about Vumerity in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Vumerity is an oral fumarate prodrug that is rapidly converted in vivo to monomethyl fumarate, the same active metabolite delivered by dimethyl fumarate. The clinical rationale for Vumerity over dimethyl fumarate is the GI-tolerability profile observed in comparative studies. Vumerity is taken twice daily with food. Initiation uses a 7-day starter dose (231 mg twice daily), stepping up to the maintenance 462 mg twice daily.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Eligibility requires a confirmed relapsing MS diagnosis per McDonald criteria, MRI evidence, and a clinical rationale. Before starting, your neurologist will establish complete blood count including absolute lymphocyte count, baseline liver function tests, and review for progressive multifocal leukoencephalopathy (PML) risk factors. During therapy, CBC with lymphocyte count is rechecked at six months and every 6-12 months thereafter; LFTs are monitored periodically. Flushing, a known fumarate-class effect, is managed with administration after food, aspirin pre-medication where appropriate, and patient counselling that flushing typically declines within the first month of therapy.
Is Vumerity legally importable into the UAE?
Yes, through the MoHAP named-patient import framework. The mechanism permits an Emirati-licensed physician to import a medicine not locally registered when (a) the medicine is approved by a recognised reference authority such as the US FDA, (b) no clinically equivalent registered alternative is suitable, (c) the physician accepts clinical responsibility, and (d) chain of custody is documented. Fumarate-class named-patient imports for MS are a familiar category for MoHAP reviewers.
How the pathway works, step by step
- Consultation with your treating neurologist. Confirmation of MS subtype, MRI review, prior DMT history, and clinical rationale for Vumerity over other fumarates or DMTs.
- Baseline workup. CBC with lymphocyte count, LFTs, PML risk review.
- MoHAP named-patient application. The physician or hospital pharmacy files the application including clinical rationale, patient reference, titration plan, and chain-of-custody commitment.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure Vumerity from authorised distribution under DSCSA.
- Ambient shipment. Vumerity ships under controlled ambient conditions with chain-of-custody documentation.
- Arrival and first dose. The dispensing pharmacy releases the 7-day starter pack with flushing-management counselling; maintenance dosing continues at home.
What documentation your physician needs
- Clinical rationale letter confirming relapsing MS and Vumerity as the indicated therapy
- Verification of the UAE medical licence (SCFHS)
- MRI report supporting the diagnosis
- CBC with lymphocyte count and LFTs
- PML risk-factor review
- Planned titration schedule and monitoring plan
- Flushing-management counselling plan
Reserve Meds provides a physician documentation kit bundling templates MoHAP reviewers expect for fumarate MS named-patient imports.
Typical costs and indicative timing
Medicine price: quote on request. You get a written quote for your case before you commit. International logistics, MoHAP documentation handling, and coordination add incremental cost. Reserve Meds issues a transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Monthly refills are generally faster once the pathway is established.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
A brief culturally-aware note: Ramadan and Hajj seasons can affect scheduling and refill timing. Our team coordinates the monthly cycle with your family's preferences.
Reserve Meds's role
- Sourcing. Through our US-licensed pharmaceutical wholesale partner under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and MoHAP review.
- Logistics. Ambient-controlled shipment to your prescribing hospital pharmacy.
- Dedicated case lead. A named point of contact coordinating monthly refills.
What we do not do: we are not the prescriber, do not practise medicine, and are not the dispensing pharmacy. All clinical decisions remain with your treating neurologist.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP named-patient framework with appropriate documentation. See our trust and compliance page.
How is Vumerity different from Tecfidera? Vumerity (diroximel fumarate) and Tecfidera (dimethyl fumarate) deliver the same active metabolite, monomethyl fumarate. Vumerity's clinical-trial GI-tolerability profile generally shows lower rates of gastrointestinal adverse events. Your neurologist selects based on the specific tolerability situation and prior fumarate experience.
What about flushing? Flushing is a known fumarate-class effect. Administration after food and, where appropriate, aspirin pre-medication reduce frequency and severity. Flushing typically declines in intensity within the first month of maintenance therapy.
What is PML and why the risk review? Progressive multifocal leukoencephalopathy is a rare but serious brain infection seen with certain immunomodulatory therapies, including fumarates. Risk factors and lymphocyte monitoring are part of routine MS care and FDA labelling.
Will private insurance cover this? Cash-pay is the default. Some UAE private insurers consider named-patient imports case by case; we supply documentation but do not process claims directly.
Next step
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy, not the prescriber, and not the manufacturer. Cash-pay. Export-only (US → overseas). Composite case examples. Not medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-24.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Vumerity in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Vumerity for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Vumerity in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Vumerity. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Vumerity in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Vumerity to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Vumerity to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Vumerity in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Vumerity in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.